未登录

S

Shenghua Liu

Huashan Hospital

H指数:9

被引数:314

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytoskeletal protein KRT14 governs cisplatin resistance by modulating eIF4H-dependent ACOX2 translation and lipid metabolism in bladder cancer

细胞骨架蛋白KRT14通过调节eIF4H依赖的ACOX2翻译和脂质代谢来调控顺铂耐药性在膀胱癌中的作用

Cell Death & Disease

IF9.6

2025-12-240

OAAI

Design of alveolar biomimetic enhanced heat transfer structure for cylindrical lithium battery pack

JOURNAL OF ENERGY STORAGE

IF9.8

2024-11-011

PRE

Urinary exosomes: Potential diagnostic markers and application in bladder cancer

尿外泌体: 潜在的诊断标志物及其在膀胱癌中的应用

IF3.6

2024-06-013

OAAI

Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer

BIOENGINEERING-BASEL

IF3.7

2023-03-027

OAAI

Bladder cancer-associated microbiota: Recent advances and future perspectives

膀胱癌相关微生物群: 最新进展和未来展望

IF3.6

2023-01-0115

OAAI

Metabolic-associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer

与膀胱癌免疫微环境和预后相关的代谢相关特征和枢纽基因

MOLECULAR CARCINOGENESIS

IF3.2

2022-10-178

OA

Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-02-243

OAAI

Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer

基于磁共振成像的影像组学标记对膀胱癌Ki67表达的术前预测

IF3.5

2021-12-0426

OAAI

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-293

OAAI

Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-1328

OAAI